Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Artesunate by Frantz Viral Therapeutics for Human Papillomavirus Infections: Likelihood of Approval
Artesunate is under clinical development by Frantz Viral Therapeutics and currently in Phase II for Human Papillomavirus Infections. According to...
Data Insights
Artesunate by Gilead Sciences for Precancerous Condition: Likelihood of Approval
Artesunate is under clinical development by Gilead Sciences and currently in Phase I for Precancerous Condition. According to GlobalData, Phase...